MiNK Therapeutics raises ~$5.8M via 4.64M shares at $1.25/share, 25% premium to VWAP

MiNK Therapeutics, Inc.

Issued 4,640,000 common shares at $1.25 per share, a 25% premium to 30-day VWAP.
Net proceeds of approximately $5.8 million after offering expenses.
Transaction closed on May 14, 2024.
Registration statement due by Aug 15, 2024; investor locked up until Nov 9, 2024.
Investor agrees to vote shares in line with board recommendation through May 14, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.